IQ IQE IQE plc Loading... : Bullish and Bearish Analyst Opinions

Author is bullish on photonics and AI infrastructure based on Marvell CEO's Computex CPO thesis and supply-chain confirmations, but lists beneficiaries as a research basket rather than explicit positions.

Speaker lists these tickers as potentially interesting in reply to a request, with no further analysis or catalyst.

Buy IQE on pullbacks to 10/20 EMA support (49–47p); highest close since 73p suggests momentum building toward 56–58p resistance breakout.

Author sold SIVE and LWLG for IQE, citing bearish short-term chart on LWLG and risk management on SIVE, but no forward position or catalyst is stated.

Long IQE since last year, still holding through the strong run.

The author corrects a prior research error and reframes IQE as upstream of CPO and Western defence, not a generic optical play, without stating a personal position.

Buy IQE as a pure-play upstream supplier to co-packaged optics (CPO) via Quintessent QD laser/SOA wafer supply (Jan 2025, CW-WDM MSA ecosystem) and Western GaN RF defence where ITAR/export controls structurally exclude Asian competition; MACOM's £45m strategic anchor with 2 board seats and multi-tech LTSAs de-risks the thesis.

Buy IQE as the only scaled Western merchant pure-play epitaxy supplier to the AI optical interconnect stack (InP wafers for Lumentum, MACOM, Coherent); speaker has rotated into the position, FY26 revenue guided >20% YoY, MACOM strategic anchor provides balance sheet stability, and valuation trades at ~6x FY26 sales vs comparable LandMark Optoelectronics at ~17x — a large gap with regulatory moat in Western defence limiting Asian competition.

Buy IQE as the sole scaled Western merchant compound semiconductor epitaxy pure-play, trading at 4x FY26 sales vs. direct peer LandMark Optoelectronics at 96x; MACOM anchor deal, >20% FY26 revenue guidance, and InP capacity build for AI optical interconnects provide fundamental support, with H1 FY26 interim results (~September) as the quantified margin catalyst.

Author discloses adding to an existing $IQE position, signaling continued conviction in the holding despite short-term volatility.

Author mocks a previous trade by noting IQE and SIVE gains but does not state a current position or forward call.

Author mocks a parent poster's trades by noting IQE and SIVE price moves, but does not state a personal position or forward call.

The author provides a technical analysis of IQE noting a strong bounce off support but is watching the 56-58p resistance zone for confirmation before taking a directional view.

Listed as part of a TA update watchlist; no directional view stated.

Author thanks IQE for being green and notes past long entry at $12-13, but the tweet is a historical past-tense description and supply-chain context, not a new position call.

Buy IQE after a confirmed breakout-and-retest of prior resistance, with the stock showing relative strength while semiconductor peers sell off; targets 82 (50% off) then 114 (remaining 50%), riding compound semiconductor wafer demand tailwind.

Author notes the stock was recently at 32 and suggests following another user for better entry timing, without stating a personal position.

Buy IQE/IQEPF as MACOM's £81M strategic investment has cleared HSBC debt and ended 18 months of covenant uncertainty; InP demand for AI data centre optical interconnects is accelerating with Tier 1 design wins in hand, GaN RF qualifications for LEO satellites progressing, and management guiding >20% FY2026 revenue growth. [Manual alias cleanup: in author text and in quoted context refer to the same IQE plc instrument; retained IQEPF as the visible trade idea and removed duplicate IQE WATCH stub.]

The author apologizes and directs to another user's page for more posts on IQE, without stating any personal position or forward view.

Author asks for more information on IQE after seeing increased discussion but has not taken a position yet.

Buy IQE around 45.5–47p where price aligns with the 10/20 EMA and 0.236 Fib retracement; alternatively enter on confirmed breakout above 56–58p resistance. Author is actively rotating capital into the position, confirming conviction.

Author added to an existing long position in IQE, indicating increased conviction in the company's asymmetric risk/reward setup.

Named in AI enabler basket list (photonics/semis); no explicit ownership or position language per speaker note standard.

Author thanks the parent for taking positions but advises doing own research rather than blindly following, so no personal directional view is expressed.

Author assigns a 3x upside target to IQE; no supporting catalyst or valuation methodology provided in the tweet.

Author re-entered IQE at meaningful size after a prior exit, indicating a deliberate re-conviction decision rather than a passive hold — strongest signal among the adds.

Watch IQE as a European compound semiconductor name better positioned to benefit from EU supply chain buildout rather than US redomestication; no explicit position taken.

The author clarifies that ASYS is a medium-to-long-term play and shifts focus to IQE as a more appropriate near-term beneficiary, without stating a personal position.

Speaker identifies a bullish technical formation on IQE with specific entry levels at 45.5–47p (10/20 EMA / 0.236 Fib) and a breakout watch above 56–58p resistance; no personal position disclosed.

Author reflects on past public trades and explainers for IQE, LPK, and ASTS without stating a current position or forward-looking view.